Skip to Main Content

Paper Details

Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapy.
Leuk Res
2
2021
Author NameAffiliation
Martin S TallmanMemorial Sloan Kettering Cancer Center
  • 1 - 1

Datasets

Release 1.2